Breaking Julian Sayin Named Ohio State Football Captain Amidst Growing Leadership Role Trump Administration Announces Venezuela Oil Deal Amidst Unclear Details Commentator Milo Yiannopoulos Deported From U.S. to U.K. Tadej Pogacar Withdraws From Spanish Vuelta After Stage Eight Crash Federal Reserve Chair Suggests Potential Interest Rate Hikes Amid Persistent Inflation

Saturday August 29, 2026

Section

Press Releases

Press Release

Stunning Second-Weekend Momentum for THE ODYSSEY Drives the Most Successful IMAX Run in AMC Theatres History

Business Wire · Jul 27

Press Release

TransDigm Announces Acquisition of Prince & Izant

TransDigm Group Inc. · Jul 27

Press Release

Gossamer Bio Announces FDA Regulatory Update and Reacquisition of Worldwide Rights Related to Seralutinib and Provides a Business Update

Business Wire · Jul 27

Press Release

USAA Unveils The National Military Monument™, Honoring More Than 41 Million Americans Who Have Answered the Call to Serve Since the Revolutionary War

Business Wire · Jul 27

Press Release

AstraZeneca results: H1 and Q2 2026

Business Wire · Jul 27

Press Release

Bank of Hawai‘i Corporation Second Quarter 2026 Financial Results

Business Wire · Jul 27

Press Release

GCT Semiconductor Holding, Inc. to Give Business Update and Announce Second Quarter 2026 Financial Results on August 10, 2026

Business Wire · Jul 27

Press Release

Sonesitatug vedotin demonstrated a statistically significant and highly clinically meaningful improvement in overall survival in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers

Business Wire · Jul 27

Press Release

PulteGroup’s Built to Honor Program Helps 10 Veteran Families Build Stronger Futures in 2026

Business Wire · Jul 27

Press Release

Boost Run Announces Warrant Redemption

Business Wire · Jul 27

Press Release

Oklo Announces Date for Second Quarter 2026 Financial Results and Business Update Call

Business Wire · Jul 27

Press Release

Liberate Bio Appoints Steven H. Bernstein, M.D., as Chief Medical Officer to Advance In Vivo Cell Programming Toward the Clinic

Business Wire · Jul 27

Press Release

Yarrow Bioscience Announces Closing of Merger with VYNE Therapeutics and Initiation of Dosing in Phase 2a/2b Trial of YB-101, a Potential First-in-Class Treatment for Graves’ Disease and Thyroid Eye Disease

Business Wire · Jul 27

← Previous 1 … 3,704 3,705 3,706 … 3,851 Next →